FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to production of genetically engineered structures for expression of transgenes in cells of mammals, and can be used for recombinant production of platelet-derived growth factor.
EFFECT: for effective expression in cells of mammals optimised gene of platelet growth factor (PDGF-B), sequence of nucleotides which is presented in Figure 1.
1 cl, 3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATING RECOVERED PERIPHERAL TISSUE INNERVATION | 2011 |
|
RU2486918C1 |
VEGFopt GENE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR | 2008 |
|
RU2385937C1 |
METHOD FOR STIMULATING RESTORATION OF TISSUE INNERVATION FOLLOWING INJURIES AND ISCHEMIA BY MEANS OF VECTOR CONSTRUCT | 2013 |
|
RU2538621C2 |
HGFopt GENE OF HEPATOCYTE GROWTH FACTOR | 2008 |
|
RU2385936C1 |
METHOD OF STIMULATING RECOVERY OF DAMAGED TISSUE INNERVATION | 2014 |
|
RU2563541C1 |
AGPopt GENE OF ANGIOPOIETIN-1 | 2008 |
|
RU2385938C1 |
METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
PICHIA PASTORIS 2-2 YEAST STRAIN AS PRODUCER OF HUMAN PLATELET GROWTH FACTOR (PDGF-BB) AND METHOD FOR PRODUCTION OF HUMAN PLATELET GROWTH FACTOR | 2005 |
|
RU2290434C1 |
METALLOPROTEINASE-8 MMP8opt GENE | 2008 |
|
RU2378376C1 |
GENETIC ENGINEERING STRUCTURE FOR ANGIOGENESIS STIMULATION | 2019 |
|
RU2737487C1 |
Authors
Dates
2016-07-10—Published
2014-08-26—Filed